Marshall University

Marshall Digital Scholar
Biochemistry and Microbiology

Faculty Research

Spring 4-6-2007

Identification of a pool of non-pumping Na/KATPase
Man Liang
Jiang Tian
Lijun Liu
Sandrine Pierre PhD
Marshall University

Jiang Liu
Marshall University, liuj@marshall.edu
See next page for additional authors

Follow this and additional works at: http://mds.marshall.edu/sm_bm
Part of the Medical Biochemistry Commons
Recommended Citation
Liang M, J Tian, L Liu, S Pierre, J Liu, J Shapiro, and ZJ Xie. 2007. Identification of a pool of non-pumping Na/K-ATPase. J. Biol.
Chem. 282:10585-93.

This Article is brought to you for free and open access by the Faculty Research at Marshall Digital Scholar. It has been accepted for inclusion in
Biochemistry and Microbiology by an authorized administrator of Marshall Digital Scholar. For more information, please contact
zhangj@marshall.edu, martj@marshall.edu.

Authors

Man Liang, Jiang Tian, Lijun Liu, Sandrine Pierre PhD, Jiang Liu, Joseph I. Shapiro M.D., and Zi-jian Xie

This article is available at Marshall Digital Scholar: http://mds.marshall.edu/sm_bm/112

THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 282, NO. 14, pp. 10585–10593, April 6, 2007
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.

Identification of a Pool of Non-pumping Na/K-ATPase*
Received for publication, September 27, 2006, and in revised form, February 6, 2007 Published, JBC Papers in Press, February 12, 2007, DOI 10.1074/jbc.M609181200

Man Liang‡1, Jiang Tian‡1, Lijun Liu‡, Sandrine Pierre‡, Jiang Liu§, Joseph Shapiro§, and Zi-Jian Xie‡§2
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Recent studies have ascribed many non-pumping functions to
the Na/K-ATPase. Here, we present experimental evidence
demonstrating that over half of the plasma membrane Na/KATPase in LLC-PK1 cells is performing cellular functions other
than ion pumping. This “non-pumping” pool of Na/K-ATPase,
like the pumping pump, binds ouabain. Depletion of either cholesterol or caveolin-1 moves some of the “non-pumping” Na/KATPase into the pumping pool. Graded knock-down of the ␣1
subunit of the Na/K-ATPase eventually results in loss of this
“non-pumping” pool while preserving the pumping pool. Our
prior studies indicate that a loss of the non-pumping pool is
associated with a loss of receptor function as evidenced by the
failure of ouabain administration to induce the activation of Src
and/or ERK. Therefore, our new findings suggest that a substantial amount of surface-expressed Na/K-ATPase, at least in some
types of cells, may function as non-canonical ouabain-binding
receptors.

Na/K-ATPase is an integral membrane protein found in
most mammalian cells. It was initially discovered as an energy
transducing ion pump that transports 3 Na⫹ out and 2 K⫹ into
the cell by hydrolysis of one molecule of ATP (1, 2). This pumping process generates the transmembrane chemical and electrical gradients that are essential to the excitable activity of muscle
and nerve tissue, as well as the regulation of cell volume and a
number of Na⫹-coupled transporters. Interestingly, evidence
accumulated during the last 10 years indicates that the same
Na/K-ATPase also serves as a signaling receptor. This noncanonical function depends on interactions of the Na/KATPase with various proteins including protein and lipid
kinases, membrane transporters, channels, and cellular receptors (3– 6). Binding of either endogenous or exogenous cardiotonic steroids, such as ouabain, to this receptor/protein
complex evokes protein and lipid kinase cascades, thus generating a large number of secondary messengers (4, 7–10). Specifically, we have shown that the Na/K-ATPase is capable of
interacting with Src via multiple domains in vitro. Furthermore,
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the interaction between the Na/K-ATPase and Src keeps Src in
an inactive state. Binding of ouabain to the Na/K-ATPase/Src
complex changes the interaction, resulting in activation of the
associated Src (4). In cultured cells, the receptor Na/K-ATPase
resides with Src in caveolae (11). Once the Na/K-ATPase/Src
complex is activated by ouabain, it stimulates tyrosine phosphorylation of downstream effectors, which in turn recruits
additional kinases and adaptor proteins to the activated receptors, resulting in the activation of protein kinase cascades and
the generation of second messengers (4).
To further prove the above Na/K-ATPase-specific signaling
mechanism, we have generated several ␣1 knock-down cell
lines using a siRNA-based approach. These cell lines (e.g. A4-11
and PY-17) were cloned from LLC-PK1 cells that were transfected with an ␣1-specific siRNA-expressing vector (12). While
A4-11 cells express about 44% of ␣1 subunit in comparison to
the control P-11 cells, PY-17 cells contain only 8% of the ␣1
subunit. Functional studies indicated that graded knock-down
of ␣1 decreased the interaction between the Na/K-ATPase and
Src, and resulted in an increase in basal Src activity. Concomitantly, it also abolished ouabain-induced activation of Src and
the downstream protein kinase cascade (12). These findings
clearly demonstrate that there is a pool of Src-interacting
Na/K-ATPase, thus providing further support to the above
newly discovered cellular signaling mechanism. They also suggest that there may be two functionally separable pools of
Na/K-ATPase in the plasma membrane, one performing the
canonical (pumping) function, the other carrying out non-canonical functions such as signal transduction and scaffolding.
To test this hypothesis, we have further characterized the ionpumping activity of Na/K-ATPase in the established ␣1 knockdown cells. The data presented here clearly demonstrate the
existence of a pool of non-pumping Na/K-ATPase in the
plasma membrane.

EXPERIMENTAL PROCEDURES
Materials—Image-iT FX signal enhancer, Antifade kit, Alexa
Fluor 488-conjugated anti-mouse/rabbit IgG and Alexa Fluor
546-conjugated anti-rabbit IgG antibodies were obtained from
Molecular Probes (Eugene, OR). Anti-Na/K-ATPase ␤1 (clone
C464.8) antibody was from Upstate (Lake Placid, NY); antiGiantin antibody was from Covance (Berkeley, CA). The monoclonal anti-␣1 antibody (␣6F) was obtained from the Developmental Studies Hybridoma Bank at the University of Iowa. All
the secondary horseradish peroxidase-conjugated antibodies
were from Santa Cruz Biotechnology (Santa Cruz, CA). Radioactive 86Rb⫹ and [3H]ouabain were from PerkinElmer Life Science Products (Boston, MA).
JOURNAL OF BIOLOGICAL CHEMISTRY

10585

Non-pumping Na/K-ATPase
Cell Culture—The ␣1 knock-down stable cell lines were generated from LLC-PK1 cells and cultured in Dulbecco’s modification of Eagle’s medium (DMEM)3 as described (12). Most of
the experiments were performed after the cells reached 90%
confluence. To test whether polarity affects the conclusion of
our studies, cells were also cultured on Transwell inserts and
used when the monolayer was formed (13). Because serumstarved cells were used for our prior studies of non-pumping
function of the Na/K-ATPase (12), to be consistent, cells were
serum-starved for 12 h and then used for studies of pumping
functions.
Cell Surface Biotinylation, Streptavidin Precipitation, and
Immunoblot—Labeling with biotin of plasmalemma proteins
was performed with modifications according to the protocol
described by Gottardi et al. (14). Specifically, cells grown on
60-mm Petri dishes were washed once with a nominally Ca2⫹free DMEM (15), and placed on ice. Afterward, the cells were
rinsed twice with ice-cold PBS (137 mM NaCl, 2.7 mM KCl, 10
mM Na2HPO4, 2 mM KH2PO4, pH 7.4) and incubated with 2 ml
of NHS-ss-biotin freshly diluted into biotinylation buffer (10
mM triethanolamine, pH 9.0, 150 mM NaCl) for 25 min at 4 °C
with very gentle horizontal motion to ensure mixing. Cells were
rinsed twice with PBS containing 100 mM glycine, and washed
in this buffer for 20 min at 4 °C to make certain that all of the
un-reacted biotin was quenched. Cells were then rinsed twice
with PBS to wash away the quenched biotin, and solubilized in
900 l of lysis buffer (1% Triton X-100, 150 mM NaCl, 5 mM
EDTA, 50 mM Tris, pH 7.5) for 60 min on ice. Cell lysates were
clarified by centrifugation at 14,000 ⫻ g for 10 min at 4 °C.
Control experiments showed that nearly all of the cellular
Na/K-ATPase was solubilized, which is consistent with prior
observations (16). To label the cells grown on Transwell inserts,
the same protocol was followed after the cells were first incubated in PBS solution containing 1 mM EDTA for 5 min (14).
Biotinylation buffer was then added to the apical side of the
Transwell. According to Gottardi et al. (14), pretreatment of
polarized cell cultures with PBS-EDTA solution completely
opens the tight junction for the apically added biotinylation
buffer to access the basolateral Na/K-ATPase (14). The cleared
cell lysate (750 l) was collected and incubated overnight with
100 l of packed streptavidin-agarose beads at 4 °C with endover-end rotation. The supernatant was then collected, and
1:10 of the total volume was loaded on the polyacrylamide gel as
unbound fraction (U), together with 1:10 of the cleared lysate as
total (T). Protein signal was detected using an ECL kit and
quantified by Bio-Rad GS-670 imaging densitometer.
Confocal Fluorescence Microscopy—The subcellular localization of Na/K-ATPase ␤1 subunit and Giantin was analyzed by
immunofluorescence staining. Cells cultured on cover slips
were washed twice with PBS and fixed with methanol prechilled
at ⫺20 °C. The fixed cells were then rinsed with PBS for three
times and blocked with 200 l of Image-iT FX signal enhancer
for 30 min at room temperature. Cells were then incubated with
primary antibodies (anti-Na/K-ATPase ␤1 and anti-Giantin) in
PBS containing 1% bovine serum albumin for 1 h, followed by
3

The abbreviations used are: DMEM, Dulbecco’s modified Eagle’s medium;
PBS, phosphate-buffered saline; M␤CD, methyl-␤-cyclodextrin.
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incubation with secondary Alexa Fluor-conjugated antibodies.
Image visualization was performed by Leica TCS-SP2 laser
scanning microscope (Leica, Mannheim, Germany).
Ouabain-sensitive 86Rb⫹ Uptake—Ouabain-sensitive 86Rb⫹
uptake was employed to measure the transport function of
Na/K-ATPase (17). Cells were cultured in 12-well plates to 90%
confluence, washed, and serum-starved overnight. After washing once with the fresh medium, the cells were incubated in the
same medium at 37 °C for 10 min in the presence of different
concentrations of ouabain. Monensin (20 M) was added to
clamp intracellular Na⫹ to ensure maximal capacity of active
uptake (18). Then, 86Rb⫹ as the tracer for K⫹ (1 Ci/well) was
added to start the uptake experiment. After 10 min, 3 ml of
ice-cold 100 mM MgCl2 was added to stop the 86Rb⫹ uptake.
Cells were then washed three times with the same solution.
Trichloroacetic acid-soluble 86Rb⫹ was measured by a liquid
scintillation counter. Trichloroacetic acid-precipitated protein
was dissolved in 0.1 N NaOH, 0.2% SDS solution for protein
assay. Preliminary experiments showed that the uptake was a
linear function of time for up to 20 min. Ouabain-sensitive
86
Rb⫹ uptake was about 85% of the total in control P-11 and
LLC-PK1 cells, and about 70% in PY-17 cells. To test whether
tight junction affects the measurement of 86Rb⫹ uptake in different cell lines, cells were incubated in nominally Ca2⫹-free
DMEM medium containing 0.1 mM EGTA (15). Afterward, the
86
Rb⫹ uptake was conducted in this Ca2⫹-free medium as
described in the above paragraphs. Prior studies have demonstrated that removal of extracellular Ca2⫹ was sufficient to open
up tight junction (14, 19, 20). For experiments using cells cultured on Transwell inserts, 86Rb⫹ solution was added to both
apical and basolateral sides to measure the total pumping activity. Control experiments showed that the basolateral activity
accounted for about 93% of total ouabain-sensitive 86Rb⫹
uptake. To measure Na/K/2Cl cotransporter activity, bumetanide-sensitive 86Rb⫹ uptake was conducted as previously
described (21). This activity in P-11 and PY-17 cells accounted
for less than 10 and 16% of the total uptake activity, respectively.
[3H]Ouabain Binding—The number of ouabain binding sites
in cultured cells was estimated by the protocol that had been
previously used (with modifications) and discussed (22–24).
Briefly, cells were seeded into 12-well plates, cultured to 90%
confluence, and then serum-starved overnight. Afterward, cells
were rinsed, incubated in K⫹-free Kreb’s solution (NaCl 142.4
mM; CaCl2 2.8 mM; NaH2PO4 0.6 mM; MgSO4 1.2 mM; dextrose
10 mM; Tris 15 mM; pH 7.4) in the presence of 20 M monensin
for 10 min, and then exposed to 2 M [3H]ouabain for 15 min at
37 °C. Monensin was added to clamp intracellular Na⫹ and to
prevent recycling of the Na/K-ATPase from the intracellular
pool to the plasma membrane (25, 26). Control experiments
showed that maximal binding was reached at 2 M ouabain
after 15 min of exposure in both P-11 and PY-17 cells. At the
end of incubation, cells were washed four times with ice-cold
K⫹-free Kreb’s solution, solubilized in 0.1 N NaOH/0.2% SDS,
and measured by a scintillation counter. Nonspecific binding,
measured in the presence of 5 mM unlabeled ouabain, was less
than 3% of total binding, and was subtracted from the total
binding. Control experiments showed that PY-17 cells contained 0.21 ⫾ 0.03 ng of protein/cell whereas P-11 had 0.19 ⫾
VOLUME 282 • NUMBER 14 • APRIL 6, 2007
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0.02 ng of protein/cell. The sizes of these cells are also similar:
15.0 ⫾ 2.6 m in diameter for P-11 cells and 16.0 ⫾ 2.9 m for
PY-17 cells. Thus, the binding data were normalized by the cell
numbers counted in paralleled dishes.
To test whether tight junction affects the measurement of
ouabain binding, the ouabain binding assay was performed in a
nominally Ca2⫹- and K⫹-free Krebs solution in the presence of
0.1 mM EGTA as described above. The ouabain binding sites in
P-11 cells under this condition were 8 ⫻ 105/cell, which is comparable to that (8.5 ⫻ 105/cell) in Ca2⫹-containing solution. For
binding experiments in cells cultured on Transwell inserts,
[3H]ouabain solution was added to both apical and basolateral
sides to measure the total binding. The binding activity was
normalized per mg total cellular proteins (3.6 ⫻ 1012/mg of
protein in P-11 cells).
[Na⫹]i Measurement—The relative intracellular Na⫹ content was measured according to Kim et al. (27) with minor
modifications (28). Briefly, cells cultured in 12-well plates were
incubated at 37 °C in DMEM containing trace amounts of
22
Na⫹ (0.5 Ci/ml) for 60 min. Control experiments showed
that 60 min of incubation was sufficient to fully equilibrate the
exchangeable intracellular Na⫹ with 22Na⫹ in both control and
␣1 knock-down cells. Cells were then washed three times with
ice-cold 100 mM MgCl2, and precipitated by trichloroacetic
acid. The trichloroacetic acid-extractable 22Na⫹ was measured
by a scintillation counter and the data were normalized by the
cell number.
[Na⫹]i Measurement with Fluoroprobe Sodium-binding Benzofuran Isophthalate (SBFI)—Intracellular Na⫹ concentration
was measured as previously described (15). Briefly, P-11 cells
and PY-17 cells were loaded with 5 M SBFI-AM in the presence of 0.075% pluronic for 30 min at 37 °C and then washed to
remove the excess fluorescent dye. The cells were alternately
illuminated by 340 nm and 380 nm UV light and the emission
light at 520 nm was recorded. The emission ratio of 340/380
was used to calculate intracellular Na⫹ concentration based on
the calibration curve constructed by varying extracellular Na⫹
in the presence of 10 M gramicidin. The basal [Na⫹]i concentration in P-11 cells was 20 ⫾ 2 mM (n ⫽ 15).
Data Analysis—Data presented are mean ⫾ S.E. of at least
three independent experiments, and statistical analysis was
performed using the Student’s t test.

RESULTS AND DISCUSSION
Pumping and Non-pumping Pools of Na/K-ATPase—We
have recently demonstrated that knock-down of the cellular
Na/K-ATPase reduces the size of a pool of Src-interacting
Na/K-ATPase, resulting in an increase in basal Src activity and
an inhibition of ouabain-induced Src activation (12). These new
findings led us to propose that there may be two functionally
separable pools of Na/K-ATPase in cultured LLC-PK1 cells,
one being the canonical ion pumping pool and the other being
the non-pumping pool. Because cells need the pumping Na/KATPase to survive, we reasoned that knock-down of the cellular
␣1 subunit might preferentially deplete the non-pumping pool
of Na/K-ATPase to preserve the pumping pool if these two
different pools of Na/K-ATPase co-exist in the plasma membrane. Indeed, when total Na/K-ATPase activity was measured
APRIL 6, 2007 • VOLUME 282 • NUMBER 14

TABLE 1
Comparison of Na/K-ATPase activities in different cells
Cell lines

P-11

A4-11

PY-17

␣1 content (%), n ⫽ 4
Pump activity (%), n ⫽ 4
(20 M monensin)
Bmax (%), n ⫽ 3
(Ouabain binding sites, ⫻ 104/cell)

100
100

44 ⫾ 2
46 ⫾ 2

8⫾3
42 ⫾ 3

100
(85 ⫾ 8)

45 ⫾ 4
(38 ⫾ 1)

14 ⫾ 4
(12 ⫾ 1)

in the control and the ␣1 knock-down cells, we observed that
while PY-17 cells expressed only 8% of the ␣1 protein, they
exhibited 21% of ouabain-sensitive ATPase activity in comparison to the control P-11 cells (12). These data support the
notion that there is a pool of non-pumping Na/K-ATPase in the
control P-11 cells. They also indicate that depletion of the ␣1
preferentially reduces the size of this non-pumping pool, resulting in a mismatch between the ouabain-sensitive ATPase activity and the ␣1 protein amount in the knock-down PY-17 cells.
Because the ATPase activity was measured in the presence of
alamethicin, the above assay determined the total Na/KATPase activity including the enzyme in the plasma membrane
and other intracellular compartments (29), which could overestimate the actual pumping pool of Na/K-ATPase in the
plasma membrane. Thus, to further assess how ␣1 knock-down
affects the size of the pumping pool of Na/K-ATPase in the
plasma membrane, we measured the ouabain-sensitive 86Rb⫹
uptake. Control experiments showed that ouabain-sensitive
86
Rb⫹ uptake accounted for more than 85 and 70% of total
uptake in the control and PY-17 cells, respectively. As shown in
Table 1, the reduction of the ␣1 subunit content caused a
roughly proportional decrease of the maximum pumping activity in A4-11 cells when compared with that of control P-11
cells (46 ⫾ 2% of control). However, PY-17 cells that express
8% of the ␣1 subunit still exhibited about 42% of pumping
activity. These findings provide further support to the
notion that the control P-11 cells contain a large pool of
non-pumping Na/K-ATPase.
It is important to note that the above ouabain-sensitive
86
Rb⫹ uptakes were done in the presence of 20 M monensin.
Monensin increases the intracellular Na⫹ to a degree sufficient
to maximally stimulate Na/K-ATPase activity (18). In the
absence of monensin, PY-17 cells exhibited about 66% of pump
activity compared with P-11 cells (Table 2). When intracellular
Na⫹ was measured by 22Na⫹ equilibrium assay, we observed
that the ␣1 knock-down significantly increased intracellular
Na⫹ per cell. For example, intracellular Na⫹ in PY-17 cells was
elevated to about 194% of that in P-11 cells (Table 2). To confirm these observations, we also measured intracellular Na⫹
concentration using a fluorescence probe SBFI in both P-11 and
PY-17 cells, and observed a similar relative change as measured
by 22Na⫹ equilibrium assay (Table 2). Importantly, while addition of monensin caused an 86% increase in ouabain-sensitive
86
Rb⫹ uptake because of the increased turnover rate (or
reserved pump capacity) in P-11 cells (18), it failed to do so in
PY-17 cells (Table 2). These data indicate that the pumps in
PY-17 cells operated at the maximal pumping capacity, which is
consistent with the fact that the Na⫹ content was almost doubled in these cells.
JOURNAL OF BIOLOGICAL CHEMISTRY
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TABLE 2
Intracellular Naⴙ content and monensin-induced changes in the
pump activity in different cells

a

Cell lines

P-11

Pump activity in the absence of
monensin (%), n ⫽ 4
Pump activity in the presence of
monensin (% of P-11 activity in
the absence of monensin)
22
Na⫹i (% of control ), n ⫽ 4
关Na⫹兴i (mM), n ⫽ 8

100
186 ⫾ 9

A4-11

PY-17

78 ⫾ 3

66 ⫾ 9

81 ⫾ 2

74 ⫾ 8

161 ⫾ 11
N/A

194 ⫾ 7
36 ⫾ 5

a

100
20 ⫾ 2

p ⬍ 0.05 compared to P-11 in the absence of monensin.

TABLE 3
Pumping activity and ouabain binding sites in cells cultured either in
Ca2ⴙ-free medium or on Transwell inserts (monolayer)
Ca2ⴙ-free
Cell lines
Pump activity (%), n ⫽ 4
(20 M monensin)
Ouabain binding site (%), n ⫽ 4

Monolayer

P-11
100

PY-17
46 ⫾ 3

P-11
100

PY-17
32 ⫾ 5

100

14 ⫾ 4

100

14 ⫾ 2

Because LLC-PK1 cells can form tight junction when they are
cultured at confluent density on Transwell porous inserts, it is
prudent to rule out the possibility that the potential difference
in tight junction formation among different cell lines may cause
the observed mismatch between the pumping activity and the
amount of Na/K-ATPase. Because the formation of tight junction requires the presence of extracellular Ca2⫹ (14, 19), we
repeated the above functional assays after the cultures were
incubated in a nominally Ca2⫹-free DMEM medium. As shown
in Table 3, the pumping activity in PY-17 cells was 46% in comparison to that in control P-11 cells, which is essentially the
same as that measured in the presence of extracellular Ca2⫹.
Because the above studies were done on cells cultured in
Petri dishes, to further test whether fully polarized LLC-PK1
cells also contain a large pool of non-pumping Na/K-ATPase,
we measured the pumping activity in cells cultured at confluent
density on Transwell inserts. As shown in Table 3, PY-17 cells
had about 32% of pumping activity in comparison to the control
P-11 cells. Taken together, our findings clearly show that there
is a large pool of non-pumping Na/K-ATPase in LLC-PK1 cells,
cultured either in Petri dishes or on Transwell inserts.
To test whether the ␣1 knock-down changes other K⫹
uptake mechanism, we measured Na/K/2Cl cotransporter
mediated-86Rb⫹ uptake, and observed that bumetanide-sensitive uptake activity in PY-17 cells was comparable to that in
P-11 cells (91 ⫾ 3% of PY-17 cells, n ⫽ 5, p ⬎ 0.05). However,
since intracellular Na⫹ was much higher in PY-17 cells, these
data suggest that ␣1 knock-down probably up-regulated Na/K/
2Cl cotransporter to maintain the similar transporter activity as
in control P-11 cells. Because PY-17 cells exhibited a similar cell
size as control P-11 cells, the above findings also suggest that ␣1
knock-down cells are likely adapted to the decreased Na/KATPase activity.
Surface Distribution of Na/K-ATPase—The above data indicate that there may be a large pool of non-pumping Na/KATPase in the control P-11 cells. The formation of a functional
pumping Na/K-ATPase requires the assembly of the ␣␤ complex and the subsequent delivery of this complex to the plasma
membrane. Although it is less likely, if most Na/K-ATPase in
P-11 cells resided in cellular compartments other than the
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FIGURE 1. Na/K-ATPase ␤1 expression in knock-down cells. A, total cell
lysates were analyzed by Western blot using anti-Na/K-ATPase ␤1 antibody.
P-11 is the control cell line. A4-11, PY-17, and TCN23-19 are different ␣1
knock-down cell lines. A representative Western blot is shown, and quantitative data are from four independent experiments. Values are mean ⫾
S.E. B, immunostaining of the ␤1 subunit in P-11 and TCN23-19 cells was
performed as described under “Experimental Procedures.” Giantin was
used as the Golgi marker. The same experiments were repeated three
times.

plasma membrane, this could account for the observed nonpumping pool. Thus, to rule this out, we performed the following two sets of experiments.
Because the ␤ subunit is essential for targeting Na/K-ATPase
to the plasma membrane (30), in the first set of experiments we
determined the effects of ␣1 knock-down on the expression and
cellular distribution of the ␤1 subunit. As depicted in Fig. 1A,
control P-11 cells presented at least three glycosylated ␤1
bands. The expression of these glycosylated ␤1 was significantly
reduced in both A4-11 and PY-17 cells, and the reduction was
correlated to the degrees of the ␣1 knock-down (Fig. 1A). When
the density of the ␤1 band was normalized against all three
glycosylated ␤1 bands in P-11 cells, we found that the ␤1 in
PY-17 cells was about 25% of that in P-11 cells. This was further
confirmed by Western blot analysis of deglycosylated ␤1 prepared from these cell lysates (data not shown). Interestingly,
knock-down of the ␣1 caused almost complete depletion of the
two ␤1 bands that are highly glycosylated. As depicted in Fig.
1A, under normal exposure conditions, these two species were
VOLUME 282 • NUMBER 14 • APRIL 6, 2007
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FIGURE 2. Cell surface biotinylation. A, two 60-mm dishes of PY-17 cells, one
dish of P-11 cells, and one dish of A4-11 cells were biotinylated as described
under “Experimental Procedures.” Afterward, the cells were solubilized in 900
l of lysis buffer, and then analyzed. The same volume of the unbound fraction (U) and total cell lysate (T) was subjected to SDS-PAGE and probed with
␣6F antibody. B, biotinylation assay was performed in P11 cells cultured in
Transwell inserts as described under “Experimental Procedures.” C, total ␣1
was measured by Western blot from cell lysates collected from P-11 and
PY-17 cells cultured on Tranwell inserts. Representative Western blots are
shown in each panel, and quantitative data are calculated based on at least
three independent experiments. Values are mean ⫾ S.E.

barely detectable in PY-17 cells. However, when the film was
overexposed, we were able to detect the expression of these two
species. The quantitative data indicated that PY-17 cells
expressed less than 5% of these two species in comparison to
P-11 cells. These findings were consistent with the immunostaining results depicted in Fig. 1B. While the majority of the
Na/K-ATPase ␤1 resided in the plasma membrane in control
P-11 cells, it was largely retained in the intracellular compartments in TCN23-19 cells, another ␣1 knock-down cell line that
behaves like PY-17 (12). In addition, co-immunostaining indicated that a portion of the retained Na/K-ATPase ␤1 in
TCN23-19 cells was clearly co-localized with the Golgi marker
protein, giantin. Taken together, the data showed that knockdown of the ␣1 caused a significant reduction of the plasma
membrane ␤1.
To determine surface distribution of the Na/K-ATPase and
to calculate how much surface Na/K-ATPase is required for
cellular pumping activity, we performed surface biotinylation
assay. As depicted in Fig. 2A, about 30% of ␣1 in the control
P-11 cells remained in the unbound fraction, indicating that the
other 70% was accessible to biotinylation, thus distributed in
the plasma membrane. Using the same protocol, we detected
about 19% ␣1 in the unbound fraction in A4-11 cells. However,
we failed to detect any ␣1 subunit in the unbound fraction in
APRIL 6, 2007 • VOLUME 282 • NUMBER 14

PY-17 cells even when the amount of cell lysate used for the
biotinylation assay was doubled (Fig. 2A). These data suggest
that most of the ␣1 in PY-17 cells must be targeted to the
plasma membrane. Thus, if we assume that all of the ␣1 (8% of
control) in PY-17 cells resided in the plasma membrane and
functioned as ion pumps, about 27% [Y ⫽ (8 ⫻ 100/70)/42 ⫽
0.27] of the surface ␣1 in control P-11 cells would be required
for maintaining the maximal pumping activity. Apparently,
knock-down of the ␣1 initially reduces both pumping and nonpumping pools as demonstrated in A4-11 cells. Once the maximal pumping activity is reduced to half, further reduction in ␣1
causes a preferential depletion of the non-pumping pool of
Na/K-ATPase, which is consistent with our prior observations
(12).
To further confirm this, we repeated the same measurements
in cells cultured on Transwell inserts. Interestingly, we
observed that only 13% of ␣1 in control P-11 cells was in the
unbound fraction (Fig. 2B), indicating that the other 87% was
distributed in the plasma membrane. As in cells cultured in
Petri dishes, we failed to detect any ␣1 in the unbound fraction
in PY-17 cells (data not shown). Because high density cell cultures were used, we re-measured the relative amount of ␣1 in
both control and PY-17 cells. As shown in Fig. 2C, the ␣1 in
PY-17 cells was about 11 ⫾ 3% of that in P-11 cells, which is
similar to that measured in cells cultured in Petri dishes (Table
1). Thus, if we assume that all of the ␣1 (11% of control) in
PY-17 cells resided in the plasma membrane, about 40% of surface Na/K-ATPase in control P-11 cells would be involved in
pumping. This calculation suggests that a higher percentage of
surface Na/K-ATPase may pump in the fully polarized cells
than that in cells cultured in Petri dishes. Although it is unlikely,
we cannot exclude the possibility that the activity assay conducted in cells cultured in Petri dishes might underestimate the
pumping activity caused by impaired substrate accessibility.
Ouabain Binding and Turnover Rates—The above biotinylation data indicate that there is a large pool of non-pumping ␣1
in the plasma membrane of P-11 cells. Although the ␣1 subunit
in the plasma membrane of control P-11 cells are likely to be
paired with the ␤1 subunit based on the prior studies (31, 32), it
is prudent to conduct additional experiments to ensure that the
non-pumping pool we have detected is constituted by the
Na/K-ATPase (i.e. the ␣␤ complex). To do so we measured
[3H]ouabain binding in both control and knock-down cells
because prior studies have shown that only the ␣␤ complex
binds ouabain (33).
As depicted in Table 1, P-11 cells contained about 850,000
ouabain binding sites per cell, which is similar to the reported
value in cultured Hela cells (34). However, this number is lower
than the value previously reported for LLC-PK1 cells (35).
Because serum can increase the expression of Na/K-ATPase in
cultured cells (36, 37), we believe that 12 h of serum starvation
used in our experimental condition might significantly reduce
the number of ouabain binding sites. When ouabain binding
was measured in PY-17 cells, we found that these cells contained about 115,000 sites per cell, thus 14% of the control P-11
cells. A4-11, on the other hand, expressed about 381,000 sites
per cell, 45% of that in control P-11 cells.
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Quantitatively, with 8% of the ␣1 content, PY-17 cells manifest 14% of the ouabain binding sites and carry out 42% of the
ion transport activity. We can analyze this if we make certain
assumptions. First, we assume (as supported in Ref. 12) that
there is close to zero signaling (non-pumping) pool in PY-17
cells. Second, we assume that the reason that they manifest 14%
of the ouabain binding sites with 8% of the ␣1 subunit means
that a proportion of the ␣1 is inaccessible to ouabain (e.g. the
Na/K-ATPases in recycling vesicles and the unpaired ␣1 in the
ER and later endosomes) and thus not contributing to either
86
Rb⫹ uptake or [3H]ouabain binding in P-11 cells, but they are
all accessible in PY-17. Thus, 42% of the transport activity can
be carried out by 14% of the ouabain binding sites, giving a ratio
of 3 arbitrary units of pump activity per site in PY-17 cells. For
P-11 cells, the corresponding ratio is obviously 1.0. This indicates that in P-11 cells, the maximum activity per site, even in
the presence of monensin where Na⫹ is not rate-limiting, is
1/3 ⫽ 33%. This implies that 67% of the ouabain-binding sites in
P-11 cells are non-pumping pumps, but may perform cellular
functions other than ion pumping. The only alternative interpretation is that all of the sites are pumping, but the turnover
number (pumping per site) is increased 3-fold as a result of ␣1
knockdown, which seems very unlikely. Moreover, this estimation is essentially similar to that (73%) calculated based on surface ␣1 biotinylation and the activity data. The similar ratio
(46% activity versus 14% ouabain binding site) was also
observed in cells cultured in nominally calcium-free DMEM as
shown in Table 3. In cells cultured on Transwell inserts, PY-17
cells contained about 14% of ouabain binding sites and had 32%
of pumping activity in comparison to the control P-11 cells.
Thus, about 44% of pumps in fully polarized P-11 cells are
involved in pumping. This is similar to that estimated with
biotinylation data. Taken together, both estimations indicate
that a large number of surface Na/K-ATPase is likely engaged in
cellular activities other than ion pumping.
It is known that purified renal Na/K-ATPase has a turnover
rate of 8,000 –10,000 cycles per min for ATP hydrolysis. However, when the same turnover rate was measured in cultured
cells or isolated renal tubules, the number was much lower, and
ranged from 1,500 to 5,000 cycles per min depending on cell
type (22, 34, 38, 39). Using the above ouabain-binding and
86
Rb⫹ uptake data, we calculated turnover rates of the Na/KATPase-mediated ATP hydrolysis (two K⫹ per pump cycle per
ATP hydrolysis) in the different cell lines. These calculations
revealed that the Na/K-ATPase in P-11 cells operated at about
1,600 cycles per min while the pump in PY-17 cells ran at 5,100
cycles per min. These findings are consistent with the reported
values in the literature, and with the notion that these control
cells contain a large pool of non-pumping Na/K-ATPase. They
also suggest that interaction of the Na/K-ATPase with other
cellular proteins is a key to the generation of a pool of nonpumping Na/K-ATPase. Removal of the interacting proteins
from the Na/K-ATPase during the purification may disinhibit
the enzyme, converting the non-pumping pump into pumping
pump.
In short, the above data indicate that a large pool of nonpumping Na/K-ATPase exists in cultured cells. Importantly,
this pool of Na/K-ATPase, like the pumping pump, is capable of
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binding ouabain. If this non-pumping pool is involved in transmitting the extracellular ouabain signal, it is estimated that ouabain at physiological concentration (e.g. 0.1 nM) can activate
about 2000 receptor sites per cell in LLC-PK1 cells. This activation should generate enough second messengers to change
cellular function, especially when the initial signal can be amplified via the protein kinase cascades.
A Role for Caveolae—We have shown that caveolae contain a
pool of Na/K-ATPase that interact with caveolin-1, Src, and
other signaling proteins (11, 40). Based on the structural information from SERCA and the Na/K-ATPase (41), both A (actuator) and N (nucleotide binding) domains of the ␣1 may
undergo a large and rapid conformational change during each
pump cycle. Because these domains are involved in interaction
with the signaling and structural proteins (41, 42), these interactions, in principle, might either slow down or inhibit the
movement of these functional domains; thus, the pumping
activity of the Na/K-ATPase. Conceptually, this could generate a pool of non-pumping Na/K-ATPase. Of course, not
all interacting proteins will inhibit the pumping activity of
the Na/K-ATPase. For example, when adducin was added to
the purified Na/K-ATPase, it stimulated the ATPase activity
by accelerating the E2 to E1 conformational change (43).
Nevertheless, by concentrating Na/K-ATPase and its signaling
partners, caveolae could facilitate the interactions between the
Na/K-ATPase and inhibitory proteins, thus playing a role in the
generation of a pool of non-pumping Na/K-ATPase.
We previously demonstrated that the disruption of caveolae
structure by either cholesterol depletion or siRNA-mediated
knock-down of caveolin-1 could redistribute the Na/K-ATPase
from caveolar fraction, and inhibit ouabain-activated signal
transduction in LLC-PK1 cells (11). If caveolae are involved in
assembly of the non-pumping pool of Na/K-ATPase, we would
expect that depletion of cholesterol by methyl-␤-cyclodextrin
(M␤CD) should increase Na/K-ATPase-mediated 86Rb⫹ uptake. Indeed, as illustrated in Fig. 3A, pretreatment of P-11 cells
with 10 mM M␤CD resulted in a significant increase (40% over
control) in the Na/K-ATPase-mediated 86Rb⫹ uptake. The
same effect was observed when the parent LLC-PK1 cells were
exposed to 10 mM M␤CD (data not shown). It is important to
note that the M␤CD treatment did not change the maximal
ouabain binding sites in these cells (data not shown). Significantly, when the same treatment was applied to the knockdown cells, we found no change in the pumping activity in
PY-17 cells. On the other hand, it caused a significant, but much
smaller increase in A4-11 cells. These data are consistent with
the notion that most of the Na/K-ATPase in PY-17 cells operate
as a pump whereas A4-11 cells contain reduced pools of both
pumping and non-pumping Na/K-ATPase. To further confirm
the above findings, we also measured 86Rb⫹ uptake and
[3H]ouabain binding in both control P-11 cells and caveolin-1
knock-down C2–9 cells that were derived, like P-11, from LLCPK1 cells (40). As depicted in Fig. 3B, depletion of caveolin-1
also resulted in a comparable increase in the pumping activity
per ouabain binding site. Clearly, disruption of caveolae can
convert a portion of non-pumping Na/K-ATPase into pumping
pumps. It is also clear that caveolae in LLC-PK1 cells only contain less than half of cellular non-pumping Na/K-ATPase
VOLUME 282 • NUMBER 14 • APRIL 6, 2007
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FIGURE 4. Ouabain dose-response curve. Cells were pretreated with different concentrations of ouabain as indicated for 10 min and assayed for 86Rb⫹
uptake as described under “Experimental Procedures.” Data are shown as %
of respective control value and are presented as the mean ⫾ S.E. of three
independent determinations. Curve fit analysis was performed by Graphpad
software.

FIGURE 3. A, effects of cholesterol depletion on Na/K-ATPase pumping activity. The control cells (P-11) and ␣1 knock-down cells (A4-11 and PY-17) were
pretreated with M␤CD (10 mM) at 37 °C for 1 h, washed, and then assayed for
the ouabain-sensitive 86Rb⫹ uptake activity as described. Data are shown as
% of control value of each cell line and are presented as the mean ⫾ S.E. (n ⫽
3). *, p ⬍ 0.05; **, p ⬍ 0.01. B, effects of knockdown of caveolin-1 on Na/KATPase pumping activity. The ouabain-sensitive 86Rb⫹ uptake was assayed in
both control P-11 cells and caveolin-1 knock-down C2–9 cells as described
under “Experimental Procedures.” Values are normalized per ouabain binding site, and then calculated as % of P-11 cells. Data are presented as the
mean ⫾ S.E. (n ⫽ 4). **, p ⬍ 0.01.

assuming that these treatments release all of caveolar Na/KATPase from interactions with the inhibitory proteins. Furthermore, these data indicate that the caveolar signaling Na/KATPase is capable of pumping ions once the interacting
proteins (or factors) are removed by depletion of cholesterol or
caveolin-1, which is consistent with the findings that the partially purified caveolar Na/K-ATPase has the normal ouabainsensitive ATPase activity (31).
To test whether cells other than LLC-PK1 contain a pool of
non-pumping Na/K-ATPase, we treated cultured fibroblasts
derived from the rat heart with M␤CD, and then measured for
the Na/K-ATPase-mediated 86Rb⫹ uptake. We found that the
depletion of cholesterol doubled the pumping activity in cultured fibroblasts (232 ⫾ 16% of control, n ⫽ 6). These results
suggest that an even greater majority of plasma membrane
Na/K-ATPase belongs to the non-pumping pool in fibroblasts
than that in the cells derived from renal epithelium. This is not
surprising as renal epithelial cells express a large number of
Na⫹ and K⫹ channels and transporters, thus requiring more
“pumping pumps” to keep up with the inward sodium and outward potassium “leaks.” Fibroblasts, on the other hand, are far
less “leaky.” Therefore, their pump population would contain
relatively less “pumping pumps.” Interestingly, reduction of cellular cholesterol has also been reported to increase the Na/KAPRIL 6, 2007 • VOLUME 282 • NUMBER 14

ATPase activity in several other types of cells (44, 45). For
example, depletion of cholesterol by 5–25% could increase the
pumping function by 15% in human red blood cells (44).
To assess whether the presence of a large pool of non-pumping Na/K-ATPases affect ouabain-induced inhibition of the
pumping activity, we measured the dose-dependent effects of
ouabain on 86Rb⫹ uptake in both P-11 and PY-17 cells in the
presence of 20 M monensin. As shown in Fig. 4, we found that
depletion of the cellular Na/K-ATPase increased the potency of
ouabain on cellular pumping activity. Specifically, while 357 nM
ouabain was sufficient to cause 50% inhibition of ouabain-sensitive 86Rb⫹ uptake in PY-17 cells, the same inhibition in control P-11 cells required 2131 nM ouabain (Fig. 3). Consistently,
the apparent K1⁄2 for A4-11 cells was between P-11 and PY-17
cells. Although we do not know how depletion of the cellular
Na/K-ATPase sensitizes ouabain-induced inhibition of the
pumping activity, several possibilities are worthy of discussion.
First, the existence of a large pool of non-pumping Na/KATPase may make the access of ouabain to the pumping pump
more restricted in P-11 cells. Because the expression of ␤1 was
significantly reduced in PY-17 cells, it could alter the formation
of tight junction (46), thus making PY-17 cells much leakier
than P-11 cells. However, this appears to be an unlikely explanation because if this is true, we would detect a large difference
in ouabain binding, and total pump activity among these cells
when the formation of tight junction was disrupted by removal
of extracellular Ca2⫹ (Table 3). Alternatively, the on-rate of
ouabain binding might be faster in PY-17 cells because of
increased intracellular Na⫹. However, because the assays were
conducted in the presence of monensin, it is less likely that
differences in intracellular Na⫹ among these cells can fully
account for the observed ouabain sensitivity. Finally, an
increase in ouabain sensitivity could be caused by decreased
endocytosis of the Na/K-ATPase in PY-17 cells (24, 47). It is
known that activation of the Na/K-ATPase/Src complex by
ouabain can stimulate the endocytosis of the Na/K-ATPase in
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P-11 cells (40). Because depletion of the non-pumping pool of
Na/K-ATPases blocks ouabain-induced activation of Src (12), it
is conceivable that ouabain would be less effective in stimulation of the endocytosis of Na/K-ATPase. Clearly, these issues
remain to be resolved experimentally.
In short, the above data indicate that caveolae play an important role in the organization of non-pumping pool of Na/KATPase. Moreover, the size of the non-pumping pool may vary
depending on the function of different cells as well as culture
conditions (Table 3). This is important because the size could
determine the mode of ouabain action (Fig. 4). For example, if
the size of the non-pumping pool is large enough, the physiological effects of ouabain are most likely mediated by the activation of protein kinase cascades as we demonstrated (4, 12) or
by stimulation/inhibition of other unknown protein complexes. On the other hand, if the non-pumping pool is small or
depleted, the ouabain effect is most likely because of inhibition
of the pumping activity as depicted in Fig. 4. Because Na/KATPase is very important in the economy of cells, the existence
of a pool of non-pumping Na/K-ATPase could also serve as a
reservoir for cells to rapidly and appropriately adjust to different conditions.
In summary, the evidence provided in the present study
strongly suggests the existence of a large pool of non-pumping
Na/K-ATPase in cultured cells. However, it is important to
point out an alternative possibility that this so-called nonpumping pool is constituted by a number of slow pumping
pumps that are in complex with signaling, structural and other
unknown proteins. Apparently, this non-pumping pool of
Na/K-ATPase resides in the plasma membrane. Like the pumping pumps, they are capable of binding ouabain. These findings
are significant. First, they are consistent with recent studies
from many laboratories, showing that the cellular Na/KATPase can transmit an extracellular ouabain signal independent of its pumping function. Second, they suggest that over half
of plasma membrane Na/K-ATPase, at least in some cell types,
is engaged in activities other than ion pumping. It is important
to note that these activities include, but are not limited to, the
well-characterized signal transducing functions of Na/KATPase. The Na/K-ATPase is known to interact with many
protein partners. For example, Na/K-ATPase binds phospholemman and agrin, and these interactions can either slow
the pump or keep the pump in an inactive state (48 –51). Recent
work has also revealed the interaction between the Na/KATPase and cofilin. Interestingly, this interaction appears to
play a role in the regulation of cellular metabolic activity (52).
Third, the new findings bring about many new and important
issues regarding the Na/K-ATPase. For example, how are these
two pools of Na/K-ATPase assembled, delivered, and disassembled? Furthermore, are the sizes of these pools dynamically regulated? Finally, they call for the engagement of more investigators to unravel many unknown non-canonical functions of the
Na/K-ATPase, and delineate the roles of these functions in cell
biology and animal physiology.
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